Skip to main content

Articles

Page 2 of 74

  1. Aerobic training is the primary method of rehabilitation for improving respiratory function in patients with chronic obstructive pulmonary disease (COPD) in remission. However, the mechanism underlying this im...

    Authors: Jian Li, Cai-tao Chen, Peijun Li, Xiaoyun Zhang, Xiaodan Liu, Weibing Wu and Wei Gu
    Citation: BMC Pulmonary Medicine 2024 24:154
  2. Chronic obstructive pulmonary disease (COPD) is underdiagnosed with the current gold standard measure pulmonary function test (PFT). A more sensitive and simple option for early detection and severity evaluati...

    Authors: XiaoLing Zou, Yong Ren, HaiLing Yang, ManMan Zou, Ping Meng, LiYi Zhang, MingJuan Gong, WenWen Ding, LanQing Han and TianTuo Zhang
    Citation: BMC Pulmonary Medicine 2024 24:153
  3. The coronavirus disease 2019 (COVID-19) pandemic has resulted in millions of confirmed cases and deaths globally. The purpose of this study was to investigate the therapeutic effect of airway clearance technol...

    Authors: Zhiyou Zhang, Congcong Wang, Zhendong Li, Yueyang Liu, Yutong Nie, Jianwei Zhang and Dawei Li
    Citation: BMC Pulmonary Medicine 2024 24:152
  4. The aim of the present study was to investigate the possible connection between occupational status and chronic respiratory diseases (CRDs) among the Iranian population.

    Authors: Zahra Bagheri-Hosseinabadi, Ali Bahreyni, Hosein Basirat, Parvin Khalili, Alireza Vakilian and Fatemeh Amin
    Citation: BMC Pulmonary Medicine 2024 24:151
  5. This study examined the association between chest muscles and chronic obstructive pulmonary disease (COPD) and the relationship between chest muscle areas and acute exacerbations of COPD (AECOPD).

    Authors: Ke Wang, Fan Wu, Hua He, Chengyi Hu, Xiaobang Chen, Jinglong Chen, Weitao Cao, Jun Liu, Jun Zhao, Ziwen Zhao and Zhuxiang Zhao
    Citation: BMC Pulmonary Medicine 2024 24:150
  6. Monoclonal antibodies (biologics) drastically changed severe asthma therapy. Mepolizumab (anti-interleukin (IL) 5), benralizumab (anti-IL5 receptor alpha), and dupilumab (anti-IL4/13) are the most used biologi...

    Authors: Moritz Z. Kayser, Hendrik Suhling, Jan Fuge, Christopher A. Hinze, Nora Drick, Nikolaus Kneidinger, Jürgen Behr, Christian Taube, Tobias Welte, Ina Haasler and Katrin Milger
    Citation: BMC Pulmonary Medicine 2024 24:149
  7. A multi-component self-management intervention ‘CFHealthHub’ was developed to reduce pulmonary exacerbations in adults with Cystic Fibrosis (CF) by supporting adherence to nebuliser medication. It was evaluate...

    Authors: J. M. Bradley, M. Hutchings, M. A. Arden, A. O’Cathain, C. Maguire and M. J. Wildman
    Citation: BMC Pulmonary Medicine 2024 24:148
  8. Exposure to welding fumes can lead to different respiratory health disorders, including lung cancer, due to long-term exposures. In Ethiopia, large numbers of people are engaged in the welding sector. Often, t...

    Authors: Hager Badima, Abera Kumie, Bereket Meskele and Samson Wakuma Abaya
    Citation: BMC Pulmonary Medicine 2024 24:147
  9. Transbronchial biopsy is a safe manner with fewer complications than percutaneous transthoracic needle biopsy; however, the current diagnostic yield is still necessitating further improvement. We aimed to eval...

    Authors: Jisong Zhang, Enguo Chen, Shan Xu, Li Xu, Huihui Hu, Liangliang Dong and Kejing Ying
    Citation: BMC Pulmonary Medicine 2024 24:146
  10. The potential pathogenic mechanism of idiopathic pulmonary fibrosis is widely recognized to involve immune dysregulation. However, the current pool of studies has yet to establish a unanimous agreement regardi...

    Authors: Zhao He, Ruixin Wang, Chenghu Song, Jiwei Liu, Ruo Chen, Mingfeng Zheng, Weici Liu, Guanyu Jiang and Wenjun Mao
    Citation: BMC Pulmonary Medicine 2024 24:145
  11. The causality of the relationship between bronchiectasis and chronic obstructive pulmonary disease (COPD) remains unclear. This study aims to investigate the potential causal relationship between them, with a ...

    Authors: Lei Gu, Wei Liu, Jian-an Huang, Lujian Zhu, Xiaowen Hu, Jian Yue and Jing Lin
    Citation: BMC Pulmonary Medicine 2024 24:144
  12. Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) affect a significant proportion of patients with IPF. There are limited data to inform therapeutic strategies for AE-IPF, despite its high mortalit...

    Authors: Tejaswini Kulkarni, Gerard J. Criner, Daniel J. Kass, Ivan O. Rosas, Mary Beth Scholand, Daniel F. Dilling, Ross Summer and Steven R. Duncan
    Citation: BMC Pulmonary Medicine 2024 24:143
  13. Although inverse associations have been found between medication adherence and healthcare use and spending outcomes in many clinical settings, no studies to date have examined these relationships for patients ...

    Authors: Mona Nili, Andrew J. Epstein, Dominic Nunag, Amy Olson and Bijan J Borah
    Citation: BMC Pulmonary Medicine 2024 24:141
  14. The characteristics of optimal virtual pulmonary rehabilitation (PR) for individuals with post-COVID syndrome (PCS) have not been identified. This study aimed to assess the feasibility, safety, and satisfactio...

    Authors: Antonio Sarmento, Rachel Adodo, Greg Hodges, Sandra C. Webber and Diana C. Sanchez-Ramirez
    Citation: BMC Pulmonary Medicine 2024 24:139
  15. Generic measures of health-related quality of life (HRQoL), such as the 36-Item Short Form Survey (SF-36), are widely used in assessing chronic conditions. These tools have an advantage over disease-specific i...

    Authors: Radmila Choate, Kristen E. Holm, Robert A. Sandhaus, David M. Mannino and Charlie Strange
    Citation: BMC Pulmonary Medicine 2024 24:138
  16. Yanghe Pingchuan decoction (YPD) has been used for asthma treatment for many years in China. We sought to understand the mechanism of YPD, and find more potential targets for YPD-based treatment of asthma.

    Authors: Lingyu Pan, Bangfu He, Chunxia Gong, Yehong Sun, Xianchun Duan, Yanquan Han, Jijun Chu and Yongzhong Wang
    Citation: BMC Pulmonary Medicine 2024 24:137
  17. Lung cancer (LC) is an important comorbidity of interstitial lung disease (ILD) and has a poor prognosis. The clinical characteristics and outcome of each ILD subtype in LC patients have not been sufficiently ...

    Authors: Soo Jin Han, Hyeon Hwa Kim, Dong-gon Hyun, Wonjun Ji, Chang-Min Choi, Jae Cheol Lee and Ho Cheol Kim
    Citation: BMC Pulmonary Medicine 2024 24:136
  18. Household contacts of tuberculosis (TB) patients are at a greater risk of infection and developing TB as well. Despite recommendations to actively screen such high-risk groups for TB, it is poorly implemented ...

    Authors: Habtamu Milkias Wolde, Betselot Zerihun, Waganeh Sinshaw, Delenasaw Yewhalaw and Gemeda Abebe
    Citation: BMC Pulmonary Medicine 2024 24:135
  19. Severe asthma is characterized by frequent exacerbations, altered lung function, and impaired quality of life. Tailored patient education allows for the improvement of both asthma management and quality of lif...

    Authors: Rodolphe Laurence, Julien Ancel, Maëva A. Devilliers, Sophie Carre, Sandra Dury, Valérian Dormoy, Gaëtan Deslée and Jeanne-Marie Perotin
    Citation: BMC Pulmonary Medicine 2024 24:134
  20. In epidemiological studies, the age at asthma onset is often defined by patients’ self-reported age at diagnosis. The reliability of this report might be questioned. Our objective was to evaluate the agreement...

    Authors: Elias Nurmi, Iida Vähätalo, Pinja Ilmarinen, Heidi Andersén, Leena E. Tuomisto, Anssi Sovijärvi, Helena Backman, Lauri Lehtimäki, Linnea Hedman, Arnulf Langhammer, Bright I. Nwaru, Päivi Piirilä and Hannu Kankaanranta
    Citation: BMC Pulmonary Medicine 2024 24:133
  21. This is a letter in response to an article by Ahmed et al., which concluded that in comparison to salbutamol, Fluticasone/salmeterol combination increases FEV1, FEV1% of predicted, and FEV1/FVC ratio, however it ...

    Authors: Divya Balan, Manish R Shetty and Manu K Mohan
    Citation: BMC Pulmonary Medicine 2024 24:132

    The original article was published in BMC Pulmonary Medicine 2023 23:381

  22. Bronchopulmonary dysplasia (BPD) is characterized by alveolar dysplasia, and evidence indicates that interferon regulatory factor 4 (IRF4) is involved in the pathogenesis of various inflammatory lung diseases. No...

    Authors: He Langyue, Zhu Ying, Jiang Jianfeng, Zhu Yue, Yao Huici and Lu Hongyan
    Citation: BMC Pulmonary Medicine 2024 24:130
  23. Previous observational research showed a potential link between physical activities such as walking and the risk of lung cancer. However, Mendelian randomization (MR) studies suggested there was no association...

    Authors: Fangjun Chen, Chutong Lin, Xing Gu, Yingze Ning, Huayu He and Guangliang Qiang
    Citation: BMC Pulmonary Medicine 2024 24:129
  24. With the increasing research on extracellular vesicles (EVs), EVs have received widespread attention as biodiagnostic markers and therapeutic agents for a variety of diseases. Stem cell-derived EVs have also b...

    Authors: Xuefeng Zhang, Zongyong Cheng, Menghao Zeng and Zhihui He
    Citation: BMC Pulmonary Medicine 2024 24:128
  25. The 2017 ATS/ERS technical standard for measuring the single-breath diffusing capacity (DLCO) proposed the “rapid-gas-analyzer” (RGA) or, equivalently, “total-breath” (TB) method for the determination of total...

    Authors: Rudolf A. Jörres, Christian Buess, Andreas Piecyk, Bruce Thompson, Sanja Stanojevic and Helgo Magnussen
    Citation: BMC Pulmonary Medicine 2024 24:127
  26. The long-term consequences of prematurity are often not sufficiently recognized. To address this gap, a prospective cohort study, which is a continuation of the multicenter Polish study PREMATURITAS, was condu...

    Authors: Katarzyna Walicka-Serzysko, Magdalena Postek, Urszula Borawska-Kowalczyk, Katarzyna Szamotulska, Piotr Kwaśniewicz, Krystyna Polak, Ewa Mierzejewska, Dorota Sands and Magdalena Rutkowska
    Citation: BMC Pulmonary Medicine 2024 24:126
  27. Data related to the characteristics, treatments and clinical outcomes of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) patients in China are limited, and sex differences are still a negl...

    Authors: Jiarui Zhang, Qun Yi, Chen Zhou, Yuanming Luo, Hailong Wei, Huiqing Ge, Huiguo Liu, Jianchu Zhang, Xianhua Li, Xiufang Xie, Pinhua Pan, Mengqiu Yi, Lina Cheng, Hui Zhou, Liang Liu, Adila Aili…
    Citation: BMC Pulmonary Medicine 2024 24:125
  28. While it is known that the overconsumption of ultra-processed foods (UPFs) is associated with a heightened risk of respiratory ailments, the specific effects of UPF intake on COPD remain unclear. This study wa...

    Authors: Zahra Salehi, Hanieh Malmir, Batoul Ghosn, Shokouh Onvani, Mohammad Emami Ardestani, Awat Feizi, Ahmad Esmaillzadeh and Leila Azadbakht
    Citation: BMC Pulmonary Medicine 2024 24:124
  29. Pembrolizumab is among the approved treatments for a variety of cancer types, including clear cell renal cell carcinoma (ccRCC). It has contributed to enhancing the prognosis of renal cell carcinoma. However, ...

    Authors: Oadi N. Shrateh, Yazan Abugharbieh, Yousef Abu Asbeh, Hani hour, Iyad Awad and Sami bannoura
    Citation: BMC Pulmonary Medicine 2024 24:123
  30. The existing respiratory fit test panels (RFTPs) are based on Bivariate and Principal Component Analysis (PCA) which utilise American and Chinese head and facial dimensions. As RFTPs based on local facial anth...

    Authors: Yin Cheng Lim, Shahrul Aiman Soelar, Ameerah Su’ad Abdul Shakor¹, Nadia Mohamad, Muhammad Alfatih Pahrol, Rohaida Ismail, Mahmoud Danaee and Rafiza Shaharudin
    Citation: BMC Pulmonary Medicine 2024 24:122
  31. Erlotinib is a first-generation, tyrosine kinase inhibitor of the epidermal growth factor receptor (EGFR-TKI) used for the treatment patients with NSCLC. Erlotinib is considered as a safe and effective treatme...

    Authors: Xin Yan, Jingxian Kong, Jiacheng Wang, Caixia Wang and Hongchang Shen
    Citation: BMC Pulmonary Medicine 2024 24:121
  32. A significant reduction in regional cerebral oxygen saturation (rSO2) is commonly observed during one-lung ventilation (OLV), while positive end-expiratory pressure (PEEP) can improve oxygenation. We compared the...

    Authors: Liying Zhao, Shuang Lv, Qian Xiao, Yuan Zhang, Wenbo Yi, Yu Bai, Kangping Lu, Kevin C. Bermea, Jessica Semel, Xiaomei Yang and Jianbo Wu
    Citation: BMC Pulmonary Medicine 2024 24:120
  33. Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide among people over 40 years of age, and erythrocytosis is one of the major complications associated with increased mort...

    Authors: Amon Banturaki, Dalton Kambale Munyambalu, Dickson Kajoba, Verah Bella Onchoke, Alina Peris, Prosper Ryamugwiza, Jacinto Amandua and Kingsley Akaba
    Citation: BMC Pulmonary Medicine 2024 24:119
  34. This study assessed hospitalisation frequency and related clinical outcomes among adult Aboriginal Australians with bronchiectasis over a ten-year study period.

    Authors: Timothy Howarth, Claire Gibbs, Subash S. Heraganahally and Asanga Abeyaratne
    Citation: BMC Pulmonary Medicine 2024 24:118
  35. Little attention has been paid to the pathophysiological changes in the natural history of chronic obstructive pulmonary disease (COPD). The destructions of the small airways were visualized on thoracic micro-...

    Authors: Li Li, Ying Gong, Dongni Hou, Yijun Song, Jing Bi, Miao Li, Junjie Han, Yuanlin Song and Jun She
    Citation: BMC Pulmonary Medicine 2024 24:116
  36. IgG4-related disease is a systemic fibroinflammatory disease that is mainly seen in older men, and involves multiple organs, such as the pancreas and lungs. However, 75% of patients with IgG4-related lung dise...

    Authors: Atsushi Torii, Kahori Oshima, Akari Iwakoshi and Masahide Oki
    Citation: BMC Pulmonary Medicine 2024 24:115
  37. Early diagnosing Chronic Obstructive Pulmonary Disease (COPD) is relatively difficult. Therefore, the concepts of preserved ratio impaired spirometry (PRISm) and small airway disease (SAD) were proposed to ach...

    Authors: Le Sang, Xia Gong, Yunlei Huang and Jian Sun
    Citation: BMC Pulmonary Medicine 2024 24:114
  38. Chronic obstructive pulmonary disease (COPD) is a common disease associated with premature death. Tobacco exposure is the main risk factor, but lower socioeconomic status, early life insults, and occupational ...

    Authors: Nina Brünés, Mette Bendtz Lindstroem, Charlotte Suppli Ulrik, Ove Andersen, Marianne Lisby, Nina Skavlan Godtfredsen, Tina Leth Hansen, Charlotta Pisinger, Vibeke Graven, Kristoffer Marsaa and Laura Hohwü Thomsen
    Citation: BMC Pulmonary Medicine 2024 24:113
  39. The prevalence of obstructive sleep apnea (OSA) was found to be higher in individuals following COVID-19 infection. However, the intricate mechanisms that underscore this concomitance remain partially elucidat...

    Authors: Hong Luo, Jisong Yan, Rui Gong, Dingyu Zhang, Xia Zhou and Xianguang Wang
    Citation: BMC Pulmonary Medicine 2024 24:112
  40. Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) combined with respiratory failure (RF) is a chronic respiratory disease that seriously endangers human health. This study aimed to specifica...

    Authors: Ruoqing Zhou and Dianzhu Pan
    Citation: BMC Pulmonary Medicine 2024 24:111
  41. Both sepsis and acute respiratory distress syndrome (ARDS) are common severe diseases in the intensive care unit (ICU). There is no large-scale multicenter study to clarify the attributable mortality of ARDS a...

    Authors: Dong-Hui Wang, Hui-Miao Jia, Xi Zheng, Xiu-Ming Xi, Yue Zheng and Wen-Xiong Li
    Citation: BMC Pulmonary Medicine 2024 24:110
  42. High-altitude pulmonary edema (HAPE) refers to the onset of breathlessness, cough, and fever at rest after arriving at high altitudes. It is a life-threatening illness caused by rapid ascent to high altitudes....

    Authors: Dava Tenzing, Pianduo Suolang, Deji Gesang, Duoji Suolang, Gaozhan Duan, Wangmu Ciren, Yihui Wang and Tongtian Ni
    Citation: BMC Pulmonary Medicine 2024 24:109
  43. Safely implementing transbronchial lung cryobiopsy (TBLC) in patients with interstitial lung disease (ILD) requires accurate navigation. Traditional fluoroscopy falls short in reducing the risk of post-procedu...

    Authors: Shiyao Wang, Jinmi Yang, Sa Luo, Jing Geng, Yanhong Ren, Ling Zhao, Min Liu, Dan Wang, Ying Li, Zheng Tian, Wei Liu, Guowu Zhou and Huaping Dai
    Citation: BMC Pulmonary Medicine 2024 24:108
  44. Mycoplasma pneumoniae infections have increased in China recently, causing some evidence of familial clustering. The purpose of this study was to compare the clinical features of parents and children in cases of...

    Authors: Xu Liu, Qingfeng Zhang, Hao Chen, Yueying Hao, Jingyi Zhang, Shiqian Zha, Beini Zhou, Yaohua Yi, Rui Xiao and Ke Hu
    Citation: BMC Pulmonary Medicine 2024 24:107
  45. The main focus on the characteristics of malignant lung tumours has been the size, position within the lobe, and infiltration into neighbouring structures. The aim of this study was to investigate the distribu...

    Authors: Yngvar Nilssen, Odd Terje Brustugun, Lars Fjellbirkeland, Åslaug Helland, Bjørn Møller, Sissel Gyrid Freim Wahl and Steinar Solberg
    Citation: BMC Pulmonary Medicine 2024 24:106
  46. While the prevalence of severe cases and mortality rate of coronavirus disease 2019 (COVID-19) appear to be reducing, the clinical characteristics and severity of hospitalized patients with asthma and COVID-19...

    Authors: Akinari Tsukada, Junko Terada-Hirashima, Jin Takasaki, Hiroshi Nokihara, Shinyu Izumi, Masayuki Hojo and Haruhito Sugiyama
    Citation: BMC Pulmonary Medicine 2024 24:105

Annual Journal Metrics

  • 2022 Citation Impact
    3.1 - 2-year Impact Factor
    3.5 - 5-year Impact Factor
    1.081 - SNIP (Source Normalized Impact per Paper)
    0.999 - SJR (SCImago Journal Rank)

    2023 Speed
    33 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    2,422,461 downloads
    1,250 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal